Mirati Therapeutics, Inc. | TalkMarkets

Latest Posts

About This Stock More About This Stock

These Three Biotech Stocks Are Trading At A Discount

Article By: The Tokenist

Thursday, November 23, 2023 6:02 PM EDT

Investors exposed to the biotech sector have seen mixed results this year.

In this article: IMGN, AMPH, MRTX Also: PFE

Read

Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2

Article By: The Fly

Friday, June 2, 2023 4:30 PM EDT

Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.

In this article: CHRS, AKBA, CRVS, IOVA, MRTX

Read

Healthcare Sector Still Looks Good But Lacks Momentum

Article By: Rod Raynovich

Tuesday, September 6, 2022 4:29 AM EDT

The summer rally is over it’s a holiday weekend with low trading volume and bad news is pervasive. A decent jobs report on Friday brought in buyers in early hours until Russia intervened with a Nord Stream suspension of natural gas to Germany.

In this article: IBB, XBI, XLE, MRNA, MRTX, CCXI

Read

Check Your Portfolio For Small Cap Weighting: Growth, Innovation Or Speculation?

Article By: Rod Raynovich

Monday, August 15, 2022 5:12 AM EDT

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring biotech small cap performance.

In this article: CYRX, QDEL, IWM, XBI, CCXI, EVH, ARKG, MRTX

Read

Piper Says Mirati Now 'Prime' Biotech Takeout Candidate, Boosts Target

Article By: The Fly

Thursday, November 5, 2020 5:37 AM EDT

Piper Sandler analyst Tyler Van Buren raised the firm's price target on Mirati Therapeutics to $260 from $210 and keeps an Overweight rating on the shares.

In this article: MRTX

Read

All Posts